miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellularcarcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition(ABP50351-4.29)
Date：2021-03-16
Views：354
